Latest Resources

The financialisation of malaria in Africa: Burkina Faso, rogue capital & GM /gene drive mosq...

(Veuillez cliquer ici pour lire en français) The African Centre for Biodiversity (ACB) hereby publishes a new research paper, titled, “The Financialisation of malaria: Burkina Faso, Rogue capital & GM/gene drive mosquitoes.” This paper seeks to understand the financialisation of malaria as a vehicle for rogue capital in a context of a weakened state (through […]

Coalition demands a ban of Bt Cowpea in Nigeria and neighbouring West African countries

A coalition of non-governmental organisations, farmer groups and research experts from various African countries call on the Nigerian government to revoke the permits granted by Nigeria’s National Biosafety Management Agency (NBMA) to the Institute for Agricultural Research (IAR), Zaria, for the commercial release of genetically modified (Bt) Cowpea (PBR-Cowpea). This call was made yesterday in […]

Wandile Sihlobo’s technocratic support for GM and related technology misses the mark

Southern African civil society responds to false claims about benefits to food and nutrition security The African Centre of Biodiversity joins a collective of civil society organisations to endorse Glen Ashton’s calling out of chief economist of AgBiz, Wandile Sihlobo, on his May articles in Business Day and Project Syndicate, which promote the continued use […]

Genome editing: new wave of false corporate solutions for Africa’s food systems. Forewarnings of ...

(Por favor clique aqui para Português) (Veuillez cliquer ici pour le français) African food sovereignty movement’s victory over, and continued resistance against, the biotech industry Despite two decades of biotech industry-backed lobbying, funding, relentless propaganda and backroom deals, supported by neo-colonial philanthropy-capitalists, such as Bill Gates; this machinery has very little to show. Only 2.9 […]

Tanzania cancels GMO trials again: Urgent need to uphold ban, disrupt false solutions and neo-col...

In a totally unexpected move, the newly appointed Tanzania Agricultural Minister, Prof Adolf Mkenda, in mid-January 2021 announced the cancellation of research trials involving genetically modified organisms (GMOs) in the country and the decision to put in place extra biosafety scrutiny of imported genetically modified (GM) seed. The decision was taken by the Minister in […]

Genome editing — The next GM techno fix doomed to fail

Regulatory issues and threats for Africa Veuillez cliquer ici pour le français Clique aqui para a versão portuguesa Por favor, haga clic aquí para el español Genome editing risks aggravating the problems of industrial agriculture, prolonging a model that threatens both human health and the environment, and further opens up African food systems to hegemonic […]

Push back against risky and unsafe RNAi GM cassava cultivation in Kenya

An unproven genetically modified (GM) RNAi cassava variety is yet another staple food crop, after maize and banana, on the biotech industry’s agenda for commercial cultivation in Kenya. The brazen lack of safety tests contained in the Kenya Agricultural and Livestock Research Organisation’s (KARLO’s) application for cultivation, and disregard for adherence to biosafety best practise […]

Profiteering from health and ecological crisis in Africa: The Target Malaria project and new risk...

Cliquez ici pour le français The ACB shares this research paper with you, of the wave of ‘Trojan horse’ second-generation genetic engineering strategies targeted at, inter alia, malaria in Africa, at a time when the COVID-19 crisis is fracturing the myth that global health expertise is the domain of North America and Europe. Global health […]

GM Fungi to kill Mosquitoes: Illegal experiments in Burkina Faso?

(Cliquez ici pour le français) Conducted silently and out of the public eye, a three-year experiment involving a new and potentially unsafe and risky genetically modified (GM) fungus to kill mosquitoes was performed in the village of Soumousso in Burkina Faso in 2019. When the study was published in a US scientific journal in May […]

COVID-19: Access to medicine & implications for Africa

ACB brings you a new discussion paper Passer à la version française Clique aqui para a versão portuguesa Dear Friends and Colleagues, Expeditious and affordable access to medicines and other healthcare items will be critical to reducing the toll of COVID-19 in Africa. But if nothing is done to compel corporations to make their patents […]